EGFR tyrosine kinase inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR tyrosine kinase inhibitor (investigational), covering 2025-07-24 to 2025-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations [Phase 2]